BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3626043)

  • 1. [Cell surface phenotype in chronic lymphocytic leukemia].
    Kamihira S; Monita S; Amagasaki T; Ikeda S; Yamada Y; Moriuti Y; Oyakawa Y; Ichimaru M; Kinosita K
    Rinsho Ketsueki; 1987 Apr; 28(4):513-8. PubMed ID: 3626043
    [No Abstract]   [Full Text] [Related]  

  • 2. Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells.
    Ligler FS; Schlam ML; Curley R; Brodsky I; Benzel JE
    Am J Hematol; 1983 Dec; 15(4):335-42. PubMed ID: 6196965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.
    Brown VA; Smith SK; Dewar AE; Stockdill G; Maddy AH
    Clin Exp Immunol; 1985 Oct; 62(1):95-103. PubMed ID: 3877584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
    Shawler DL; Glassy MC; Wormsley SB; Royston I
    J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin-production and surface-bound immunoglobulins in chronic lymphocytic leukemia, lymphosarcoma, and so-called reticulum cell sarcoma.
    Stein H; Kaiserling E; Lennert K
    Hamatol Bluttransfus; 1974; 14():97-106. PubMed ID: 4615050
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies.
    Mann DL; Haynes BF; Thomas C; Cole D; Fauci AS; Poplack DG
    J Natl Cancer Inst; 1983 Jul; 71(1):11-7. PubMed ID: 6602900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence studies on the surface of human lymphocytes in chronic lymphocytic leukemia.
    Rozynkowa D; Chibowski D
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):601-6. PubMed ID: 4614757
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclasses on the lymphocyte surface in chronic lymphocytic leukemia (CLL).
    Kimby E; Hammarström L; Björkholm M; Smith E; Mellstedt H
    Haematologica; 1985; 70(1):75-7. PubMed ID: 3924762
    [No Abstract]   [Full Text] [Related]  

  • 11. IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia.
    Kubo RT; Grey HM; Pirofsky B
    J Immunol; 1974 May; 112(5):1952-4. PubMed ID: 4594421
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype.
    Bloem AC; Bast EJ; Gmelig Meyling FH; DeGast GC; Ballieux RE
    Clin Exp Immunol; 1982 Nov; 50(2):355-9. PubMed ID: 6983937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
    Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
    Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia.
    Johansson B; Klein E
    Clin Exp Immunol; 1970 Mar; 6(3):421-8. PubMed ID: 4191826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface immunoglobulins of leukaemic cells.
    Foulis AK; Cochran AJ; Anderson JR
    Clin Exp Immunol; 1973 Aug; 14(4):481-90. PubMed ID: 4518234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
    Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
    Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of surface immunoglobulins from leukemic cells.
    Stevenson GT
    Br J Radiol; 1972 May; 45(533):394. PubMed ID: 5023508
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of acute lymphocytic leukemia with B-cell phenotype and with IgM/lambda cold agglutinin production].
    Ohnishi M; Koike T; Nagai K; Aoki S; Hirosawa H; Moriyama Y; Shinada S; Shibata A
    Rinsho Ketsueki; 1985 Oct; 26(10):1659-64. PubMed ID: 3937918
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations.
    Geisler C; Ralfkiaer E; Astrup L; Christensen I; Dickmeiss E; Hansen MM; Larsen JK; Petersen J; Plesner T
    Scand J Haematol; 1983 Aug; 31(2):109-21. PubMed ID: 6604307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.